Dupont Capital Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Dupont Capital Management’s Portfolio GEVA Stock Details GEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,360	Closed	-$815K	–	658
2015 Q1	$815K	Hold	8,360	–	–	0.02%	470
2014 Q4	$776K	Hold	8,360	–	–	0.01%	506
2014 Q3	$575K	Sell	8,360 -8,600	-51%	-$616K	0.01%	543
2014 Q2	$1.78M	Buy	+16,960	New	+$1.44M	0.03%	397

Dupont Capital Management's GEVA Position: Q2 2015 in Review

Dupont Capital Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 8,360 shares — an estimated $815K sold.

Dupont Capital Management first reported a position in GEVA in Q2 2014 and held it in 4 quarters. The position peaked at $1.78M in Q2 2014. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

Dupont Capital Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Dupont Capital Management sold 8,360 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $815K.
Dupont Capital Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2014 and held it in 4 quarters.
Dupont Capital Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.78M in Q2 2014.
0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Dupont Capital Management's 13F filing for Q2 2015, filed 3 Aug 2015.